Cancer

CNS Pharmaceuticals (NASDAQ: CNSP) to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Live webcast presentation on Wednesday, September 13th at 10:30 AM ETHOUSTON, TX / ACCESSWIRE / September 5, 2023 / CNS…

10 months ago

Viracta Therapeutics to Host R&D Day on October 4, 2023

SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. (Nasdaq: VIRX), a clinical-stage precision oncology company focused on…

10 months ago

Immutep to Participate in September Investor Conferences

SYDNEY, AUSTRALIA, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage…

10 months ago

Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13th

SOLANA BEACH, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on…

10 months ago

IMUNON to Participate in the H.C. Wainwright Global Investment Conference

LAWRENCEVILLE, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, announces that management will…

10 months ago

MindBio Therapeutics Announces Major Genetic Discovery in Microdosing Research

Genetic Discovery: MindBio's genetic testing in clinical research yields novel discovery for targeted diagnosis and treatmentSignificant Intellectual Property & Know…

10 months ago

Defence’s Innovative Therapeutics Featured on Viewpoint with Dennis Quaid

Vancouver, British Columbia--(Newsfile Corp. - September 5, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"…

10 months ago

Angle PLC Announces ANGLE launch of Portrait Flex assay

LAUNCH OF PORTRAIT FLEX CIRCULATING TUMOR CELL ASSAYThe Portrait Flex assay provides tailored analyses performed as a service by ANGLE's…

10 months ago

Turnstone Biologics Corp. Reports Second Quarter 2023 Financial Results and Provides Business Update

Successfully closed upsized IPO, raising $88 million in gross proceeds to continue advancing pipeline of Selected TIL Therapy programsCash position…

10 months ago